spacer
spacer
Go to PDB code: 
protein ligands Protein-protein interface(s) links
Sugar binding protein, hormone PDB-id
3g7v
Main view
    Jmol     Help!  
Contents
Description
Header details
Header records
References
PROCHECK
Protein chains
399 a.a. *
Ligands
MAL ×4
SO4 ×15
GOL ×5
Waters ×862

* Residue conservation analysis
Tools
Image Generation
AstexViewer™@PDBe
Run PROCHECK
Clefts Calculation
  
Right view Bottom view
PDB id: 3g7v
Name: Sugar binding protein, hormone
Title: Islet amyloid polypeptide (iapp or amylin) fused to maltose binding protein

Structure:
Maltose-binding periplasmic protein, islet amyloid polypeptide fusion protein. Chain: a, b, c, d. Synonym: mmbp, maltodextrin-binding protein, amylin, diabetes-associated peptide, dap, insulinoma amyloid peptide. Engineered: yes

Source:
Escherichia coli, homo sapiens. Organism_taxid: 83333,9606. Gene: male, b4034, jw3994, iapp. Expressed in: escherichia coli. Expression_system_taxid: 562.

UniProt:
Chain : ()
Pfam  

Chain : ()
Pfam  

Resolution:
1.86Å

R-factor:
0.178

R-free:
0.205

Authors:
J.J.W.Wiltzius,M.R.Sawaya,D.Eisenberg

Key ref:
J.J.Wiltzius et al. (2009). Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process.. Protein Sci, 18, 1521-1530. [PubMed id: 19475663] [DOI: 10.1002/pro.145]

Date:
10-Feb-09

Release date:
23-Jun-09

Related entries:
3g7w
Quick_links
RCSB
PDBe
SRS
MMDB
JenaLib
OCA
PDBWiki
Proteopedia
CATH
SCOP
FSSP
HSSP
PDBSWS
PQS
ProSAT
Whatcheck
EDS
Procheck
Go to PROCHECK summary
Surface
RasMol surface
spacer
spacer

 
    Key reference    
 
 
DOI no: 10.1002/pro.145 Protein Sci 18:1521-1530 (2009)
PubMed id: 19475663  
 
 
Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process.
J.J.Wiltzius, S.A.Sievers, M.R.Sawaya, D.Eisenberg.
 
  ABSTRACT  
 
Islet Amyloid Polypeptide (IAPP or amylin) is a peptide hormone produced and stored in the beta-islet cells of the pancreas along with insulin. IAPP readily forms amyloid fibrils in vitro, and the deposition of fibrillar IAPP has been correlated with the pathology of type II diabetes. The mechanism of the conversion that IAPP undergoes from soluble to fibrillar forms has been unclear. By chaperoning IAPP through fusion to maltose binding protein, we find that IAPP can adopt a alpha-helical structure at residues 8-18 and 22-27 and that molecules of IAPP dimerize. Mutational analysis suggests that this dimerization is on the pathway to fibrillation. The structure suggests how IAPP may heterodimerize with insulin, which we confirmed by protein crosslinking. Taken together, these experiments suggest the helical dimerization of IAPP accelerates fibril formation and that insulin impedes fibrillation by blocking the IAPP dimerization interface.